Page last updated: 2024-11-05

trazodone and Bruxism, Nocturnal

trazodone has been researched along with Bruxism, Nocturnal in 2 studies

Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chisini, LA1
San Martin, AS1
Cademartori, MG1
Boscato, N1
Correa, MB1
Goettems, ML1
Grinshpoon, A1
Weizman, A1
Amrami-Weizman, A1

Reviews

1 review available for trazodone and Bruxism, Nocturnal

ArticleYear
Interventions to reduce bruxism in children and adolescents: a systematic scoping review and critical reflection.
    European journal of pediatrics, 2020, Volume: 179, Issue:2

    Topics: Adolescent; Age Factors; Child; Female; Flurazepam; Humans; Male; Occlusal Splints; Patient Satisfac

2020

Other Studies

1 other study available for trazodone and Bruxism, Nocturnal

ArticleYear
The beneficial effect of trazodone treatment on escitalopram-associated nocturnal bruxism.
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:5

    Topics: Adult; Citalopram; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sleep Bruxism; Trazodone

2014